vs

Side-by-side financial comparison of FLANIGANS ENTERPRISES INC (BDL) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $52.6M, roughly 1.4× FLANIGANS ENTERPRISES INC). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 4.6%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $4.5M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 4.6%).

Flanigans Enterprises Inc. is a U.S.-based hospitality company focused on the Florida market. It operates a chain of casual dining restaurants under the Flanigan's Seafood Bar and Grill brand, plus retail package liquor stores. Its key customer segments include local residents and regional tourists, offering affordably priced seafood, American comfort food and assorted beverages.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

BDL vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.4× larger
PBYI
$75.5M
$52.6M
BDL
Growing faster (revenue YoY)
PBYI
PBYI
+23.1% gap
PBYI
27.7%
4.6%
BDL
More free cash flow
PBYI
PBYI
$9.9M more FCF
PBYI
$14.4M
$4.5M
BDL
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
4.6%
BDL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BDL
BDL
PBYI
PBYI
Revenue
$52.6M
$75.5M
Net Profit
$805.0K
Gross Margin
69.3%
Operating Margin
3.2%
22.7%
Net Margin
1.5%
Revenue YoY
4.6%
27.7%
Net Profit YoY
1363.6%
EPS (diluted)
$0.43
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDL
BDL
PBYI
PBYI
Q4 25
$52.6M
$75.5M
Q3 25
$50.0M
$54.5M
Q2 25
$51.9M
$52.4M
Q1 25
$53.4M
$46.0M
Q4 24
$50.0M
$59.1M
Q3 24
$45.4M
$80.5M
Q2 24
$48.8M
$47.1M
Q1 24
$48.1M
$43.8M
Net Profit
BDL
BDL
PBYI
PBYI
Q4 25
$805.0K
Q3 25
$896.0K
$8.8M
Q2 25
$1.4M
$5.9M
Q1 25
$2.7M
$3.0M
Q4 24
$55.0K
Q3 24
$184.0K
$20.3M
Q2 24
$1.1M
$-4.5M
Q1 24
$1.9M
$-4.8M
Gross Margin
BDL
BDL
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
BDL
BDL
PBYI
PBYI
Q4 25
3.2%
22.7%
Q3 25
3.3%
17.6%
Q2 25
5.5%
12.7%
Q1 25
6.6%
8.7%
Q4 24
1.5%
22.6%
Q3 24
0.7%
27.4%
Q2 24
4.4%
-4.6%
Q1 24
5.6%
-5.3%
Net Margin
BDL
BDL
PBYI
PBYI
Q4 25
1.5%
Q3 25
1.8%
16.2%
Q2 25
2.7%
11.2%
Q1 25
5.0%
6.5%
Q4 24
0.1%
Q3 24
0.4%
25.2%
Q2 24
2.3%
-9.6%
Q1 24
4.0%
-11.0%
EPS (diluted)
BDL
BDL
PBYI
PBYI
Q4 25
$0.43
$0.26
Q3 25
$0.48
$0.17
Q2 25
$0.75
$0.12
Q1 25
$1.45
$0.06
Q4 24
$0.03
$0.40
Q3 24
$0.11
$0.41
Q2 24
$0.60
$-0.09
Q1 24
$1.04
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDL
BDL
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$66.0M
$130.3M
Total Assets
$142.1M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BDL
BDL
PBYI
PBYI
Q4 25
$97.5M
Q3 25
$94.4M
Q2 25
$732.0K
$96.0M
Q1 25
$244.0K
$93.2M
Q4 24
$101.0M
Q3 24
$96.7M
Q2 24
$96.8M
Q1 24
$107.2M
Total Debt
BDL
BDL
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$20.9M
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$22.2M
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
BDL
BDL
PBYI
PBYI
Q4 25
$66.0M
$130.3M
Q3 25
$65.2M
$115.3M
Q2 25
$64.3M
$104.7M
Q1 25
$64.0M
$97.1M
Q4 24
$61.6M
$92.1M
Q3 24
$61.2M
$71.1M
Q2 24
$61.3M
$48.5M
Q1 24
$61.1M
$51.0M
Total Assets
BDL
BDL
PBYI
PBYI
Q4 25
$142.1M
$216.3M
Q3 25
$140.6M
$202.9M
Q2 25
$140.7M
$194.9M
Q1 25
$143.3M
$196.2M
Q4 24
$146.9M
$213.3M
Q3 24
$142.1M
$220.7M
Q2 24
$143.1M
$205.0M
Q1 24
$144.4M
$214.1M
Debt / Equity
BDL
BDL
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.32×
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
0.36×
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDL
BDL
PBYI
PBYI
Operating Cash FlowLast quarter
$4.9M
$14.4M
Free Cash FlowOCF − Capex
$4.5M
$14.4M
FCF MarginFCF / Revenue
8.5%
19.1%
Capex IntensityCapex / Revenue
0.9%
0.0%
Cash ConversionOCF / Net Profit
6.14×
TTM Free Cash FlowTrailing 4 quarters
$2.2M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDL
BDL
PBYI
PBYI
Q4 25
$4.9M
$14.4M
Q3 25
$3.4M
$9.7M
Q2 25
$1.4M
$14.1M
Q1 25
$-2.0M
$3.6M
Q4 24
$7.7M
$15.6M
Q3 24
$11.0M
Q2 24
$3.1M
$1.0M
Q1 24
$11.2M
Free Cash Flow
BDL
BDL
PBYI
PBYI
Q4 25
$4.5M
$14.4M
Q3 25
$2.4M
$9.7M
Q2 25
$-1.8M
$14.1M
Q1 25
$-3.0M
$3.6M
Q4 24
$7.0M
$15.6M
Q3 24
$11.0M
Q2 24
$2.2M
$1.0M
Q1 24
FCF Margin
BDL
BDL
PBYI
PBYI
Q4 25
8.5%
19.1%
Q3 25
4.9%
17.7%
Q2 25
-3.4%
26.8%
Q1 25
-5.5%
7.7%
Q4 24
13.9%
26.4%
Q3 24
13.7%
Q2 24
4.5%
2.1%
Q1 24
Capex Intensity
BDL
BDL
PBYI
PBYI
Q4 25
0.9%
0.0%
Q3 25
1.9%
0.0%
Q2 25
6.1%
0.0%
Q1 25
1.8%
0.1%
Q4 24
1.5%
0.0%
Q3 24
0.0%
Q2 24
1.8%
0.0%
Q1 24
0.0%
Cash Conversion
BDL
BDL
PBYI
PBYI
Q4 25
6.14×
Q3 25
3.75×
1.10×
Q2 25
1.02×
2.41×
Q1 25
-0.73×
1.21×
Q4 24
140.02×
Q3 24
0.54×
Q2 24
2.75×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BDL
BDL

Restaurant Food Sales$30.9M59%
Package Store Sales$13.3M25%
Restaurant Bar Sales$7.9M15%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons